.Merck defeats profits assumptions, brings up sales outlook on powerful requirement for best medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Estimates as Keytruda Purchases Surge BloombergMerck Sell: Pharma Giant Posts Solid End Results, But Overview Drops Short Investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats profit and also sales assumptions in the middle of Keytruda strong point, however gives mixed full-year overview MarketWatch.